MassChallenge

HeroSupport is a medical device manufacturing company founded in 2019 and based in Veyrier, Geneva. The company specializes in creating medical immobilization devices designed to enhance patient comfort during clinical procedures. Its innovative technology transforms imaging and treatment tables into personalized support solutions, specifically catering to the needs of patients undergoing prone breast radiotherapy. This approach allows patients to benefit from tailored support, eliminating the need for them to adjust to the standard table. By improving patient comfort, HeroSupport enables healthcare providers to deliver more effective and cost-efficient cancer treatment.

Exomotion SA is a Swiss company founded in 2018, located in Plan-les-Ouates, Geneva. The company specializes in the development of innovative personal mobility devices that utilize robotics technology. Exomotion's products are designed to enhance omnidirectional movement, featuring electronic movement systems that combine electrical boards with motion sensors and a wheeled mechanism. This technology enables the devices to move in any direction and rotate instantly, significantly improving the user experience. By rethinking the concept of e-mobility, Exomotion aims to enhance mobility solutions with a focus on omnidirectionality and safety.

Plair SA is a Swiss company specializing in the development and manufacturing of advanced systems for preventive environmental monitoring, particularly focusing on air quality. Founded in 2014 and based in Plan-les-Ouates, Switzerland, Plair SA designs instruments that enable continuous real-time measurements of fine airborne particles. Its notable products include the Rapid-E, which analyzes single aerosol particles, and the Particle Analyzer PA-300, capable of detecting, identifying, and classifying various airborne entities such as pollen, fungal spores, soot, and pollutants. The company offers solutions for airborne allergen monitoring, air quality assessment, and bioaerosol tracking, providing crucial data on atmospheric aerosol concentrations. Plair SA originated as a spin-off from the University of Geneva, reflecting its strong foundation in research and innovation.

Terapet specializes in advanced proton therapy for cancer treatment. Founded by physicists Christina Vallgren, Marcus Palm, and Professor Raymond Miralbell from Geneva University Hospitals, the company offers precise radiotherapy that minimizes harm to healthy cells. Incorporated in 2019, Terapet is based in Geneva, Switzerland.

Prodibi is a professional image platform based in Geneva, Switzerland, that addresses various challenges associated with online image display, enhancing brand ROI and user engagement. Established in 2011, the platform offers a subscription-based service that simplifies the process of sharing high-quality images on web and mobile. By automatically uploading, encoding, and delivering images, Prodibi allows photographers, artists, and web publishers to showcase their work without sacrificing speed or quality. The solution effectively resolves issues such as color management, pixel density, and responsiveness, which can be time-consuming and costly for graphic designers. Prodibi’s capabilities enable users to replace images seamlessly without the need for website redesigns or new photo shoots, delivering an exceptional visual experience that aligns with the prestige of their brands.

EBAMed develops a non-invasive ultrasound-based device to monitor and treat heart motion using proton beams. Founded in 2018, the company is based in Geneva, Switzerland.

GliaPharm is a Swiss biotechnology company focused on developing treatments for neurological and psychiatric disorders by targeting glial cells to support brain metabolism. It has developed the GliaX platform to identify drugs that modulate glial activity and energy metabolism. The platform combines high-throughput screening using enzymatic and primary-cell assays with metabolic characterization of compounds in vitro in primary brain cell cultures and in vivo in rodent brains. Research includes various rodent models of brain aging, Alzheimer's disease, and ALS, with selective contract research organizations handling parts of the drug-development process. Founded in 2016 and based in Geneva, GliaPharm pursues glia-mediated neuroprotection and maintenance of cognitive function.

Imverse is a Swiss-based 3D graphics software company established in 2017. Headquartered in Plan-les-Ouates, Geneva, the company specializes in deploying volumetric technology for Location Based Entertainment (LBE). Imverse offers real-time simulation and modeling tools that transform 2D images into immersive, 3D virtual environments suitable for live streaming, gaming, and remote work applications. The company's core product is a live volumetric video platform designed for enterprise use, enabling organizations to stream real-time three-dimensional holograms using depth cameras and reality capture software.